Moleculin Biotech, Inc. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
Moleculin Biotech, Inc. (MBRX) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $2.20 million as of 2020-06-30, per its 10-Q filed 2020-08-12.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2020-08-12
- 2020-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $2.20M.
- 2019-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $2.90M.
- 2019-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $3.20M.
- 2019-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $2.60M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2020-06-30 | $2.20M 10-Q · filed 2020-08-12 |
| 2019-12-31 | $2.90M 10-K · filed 2020-03-19 |
| 2019-09-30 | $3.20M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $2.60M 10-Q · filed 2019-08-16 |
| 2019-03-31 | $2.90M 10-Q · filed 2019-05-13 |
| 2018-12-31 | $3.20M 10-K · filed 2019-02-21 |
| 2018-09-30 | $3.40M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $3.80M 10-Q · filed 2018-08-10 |
| 2018-03-31 | $2.50M 10-Q · filed 2018-05-14 |
| 2017-12-31 | $2.50M 10-K · filed 2018-03-28 |
| 2017-09-30 | $1.60M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $1.30M 10-Q · filed 2017-08-11 |
| 2017-03-31 | $1.49M 10-Q · filed 2017-05-12 |
| 2016-12-31 | $1.57M 10-K · filed 2017-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |